RESUMEN
Objective: To investigate the histopathological and immunohistochemical characteristics of benign apocrine cystic papillary hyperplasia of the breast with loss of myoepithelial cell layer. Methods: The clinical data, histopathological features and immunohistochemical profile of patients with benign apocrine cystic papillary hyperplasia of breast with loss of myoepithelial cell layer from January 2016 to December 2021 were examined, in which six patients were identified. Results: All six patients were female, aged 36-61 years (median 46 years), who presented with a breast mass; three cases were from the left breast and three cases were from the right breast. Microscopic examination of all cases showed breast hyperplasia with apocrine cysts, accompanied by different degrees of micropapillary and papillary hyperplasia of apocrine cells. One case was associated with lobular carcinoma in situ, and one case was associated with apocrine ductal carcinoma in situ with intraductal dissemination in adenosis. Immunohistochemical staining of CK5/6, p63, SMA, SMMHC, Calponin and CD10 showed complete absence of myoepithelial cell layer surrounding ducts in apocrine cystic papillary hyperplasia. Conclusions: The myoepithelial cells of apocrine cystic papillary hyperplasia of the breast may undergo abnormal changes and may even be completely lost. The diagnosis should be comprehensively considered along with cytomorphological and histological features to avoid overdiagnosis.
Asunto(s)
Neoplasias de la Mama , Células Epiteliales , Glándulas Mamarias Humanas , Papiloma , Femenino , Humanos , Células Epiteliales/patología , Hiperplasia/patología , Papiloma/complicaciones , Papiloma/patología , Adulto , Persona de Mediana Edad , Glándulas Mamarias Humanas/patología , Neoplasias de la Mama/patología , Carcinoma Lobular/complicaciones , Carcinoma Ductal/complicacionesRESUMEN
INTRODUCTION: Laparoscopic pancreaticoduodenectomy(LPD)has been covered by insurance since 2016 in Japan. Advance LPD and robotic pancreaticoduodenectomy(RPD)has been also covered by insurance since 2020 in Japan. The aim of this study was to analyze the perioperative results and outcomes of RPD and LPD for the elderly patients and to compare to the non-elderly patients. PATIENTS AND METHOD: Between July 2020 and April 2023, 67 patients underwent RPD and between May 2012 and February 2021, 63 patients underwent LPD at Kansai Rosai Hospital. Sixty-seven RPD and 62 LPD patients without extended resection were divided into 2 groups those who were over 75 years old(R/LPD E)(n=55)and under 74 years old(R/LPD non-E)(n=74). Control patients who received open pancreaticoduodenectomy(OPD)without extended resection between April 2010 and April 2023 were also divided into 2 groups those who were over 75 years old(OPD E)(n =60)and under 74 years old(OPD non-E)(n=78). The patient age was 79.0 and 60.5 years, the male to female ratio was 35/20 and 45/29, disease ratio(invasive ductal carcinoma or not)was 7/48 and 9/65 in R/LPD E and R/LPD non-E groups, respectively. The patient age was 79.0 and 79.5 years, the male to female ratio was 35/20 and 31/29, disease ratio (invasive ductal carcinoma or not)was 7/48 and 30/30(p<0.0001)in R/LPD E and OPD E groups, respectively. This study was approved by the Human Ethics Review Committee of Kansai Rosai Hospital(Certificate Number: 2001019). RESULTS: The average operation time was 644.6 and 675.2 minutes, an estimated blood loss was 220.8 and 134.4 g, postoperative pancreatic fistula(ISGPS 2016, [-]/BL/Grade B/C)was 24/18/13/0 and 28/25/21/0, delayed gastric emptying(ISGPS 2007, [-]/Grade A/B/C)was 48/0/4/3 and 61/2/6/5 and postoperative hospital stay was 27.9 and 25.9 and in R/LPD E and R/LPD non-E groups, respectively. No significant differences were noted between the groups, However, postoperative complication over â ¢a Clavien-Dindo classification was 8(15.7%)and 3(4.4%)cases(p=0.0319)in R/LPD E and R/ LPD non-E groups. The average operation time was 644.6 and 492.1 minutes(p<0.0001), an estimated blood loss was 220.8 and 534.8 g(p=0.0004), postoperative pancreatic fistula(ISGPS 2016, [-]/BL/Grade B/C)was 24/18/13/0 and 27/8/24/1(p=0.0442), postoperative hospital stay was 27.9 and 42.0(p=0.0490)in R/LPD E and OPD E groups, respectively. CONCLUSION: The R/LPD was undergone in safety, even for the over 75 years old patients.
Asunto(s)
Carcinoma Ductal , Laparoscopía , Neoplasias Pancreáticas , Procedimientos Quirúrgicos Robotizados , Humanos , Masculino , Femenino , Anciano , Persona de Mediana Edad , Pancreaticoduodenectomía/efectos adversos , Neoplasias Pancreáticas/cirugía , Neoplasias Pancreáticas/complicaciones , Fístula Pancreática/etiología , Procedimientos Quirúrgicos Robotizados/efectos adversos , Estudios Retrospectivos , Laparoscopía/efectos adversos , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/etiología , Tiempo de Internación , Carcinoma Ductal/complicacionesRESUMEN
BACKGROUND/AIM: Breast cancer is a common type of cancer in Sudan. Numerous studies propose viral oncogenesis as an etiological factor for breast cancer. The aim of the study was to analyze the presence of the Epstein-Barr virus (EBV) using monoclonal antibodies against latent membrane protein 1 (LAMP1) and determine the correlation between the presence of EBV and clinicopathological characteristics. PATIENTS AND METHODS: This study used immunohistochemistry to analyze the presence of EBV in 202 samples from Sudanese women diagnosed with breast cancer. Clinicopathological data were collected from patient records from the Radiation and Isotopes Centre in Khartoum State, Republic of Sudan. RESULTS: This study included 202 patients 168 (83.2%), 16 (7.9%), and 18 (8.9%), diagnosed with invasive ductal carcinoma, invasive lobular carcinoma, and papillary carcinoma, respectively. Axillary lymph node metastasis was present in 57 (28.2%) of cases, while 11 patients (5.4%) tested positive for EBV. The mean age of patients was 48.14±14.4 years. EBV infection was more frequently detected in invasive ductal carcinoma cases, and EBV positivity was not associated with cancer type, grade, progesterone levels, and HER2 expression. On the other hand, a statistically significant association was found between EBV presence and lymph node involvement, estrogen receptor status, and age group. CONCLUSION: EBV may not play a vital role in the pathogenesis of breast carcinoma in Sudanese women.
Asunto(s)
Antineoplásicos Inmunológicos , Neoplasias de la Mama , Carcinoma Ductal , Infecciones por Virus de Epstein-Barr , Adulto , Anticuerpos Monoclonales , Neoplasias de la Mama/epidemiología , Neoplasias de la Mama/patología , Carcinoma Ductal/complicaciones , Infecciones por Virus de Epstein-Barr/complicaciones , Infecciones por Virus de Epstein-Barr/epidemiología , Infecciones por Virus de Epstein-Barr/patología , Femenino , Herpesvirus Humano 4 , Humanos , Incidencia , Masculino , Proteínas de la Membrana , Persona de Mediana Edad , Proteínas ViralesRESUMEN
The 42-year-old patient, diagnosed with Stage IIA breast cancer, completed the postoperative adjuvant chemotherapy and radiotherapy. At the 11th year of diagnosis, a 3 cm tumor was detected in the pancreas and pancreatectomy was performed. Although the diagnosis of primary pancreatic adenocarcinoma was made at first, then the pancreatic metastasis of breast cancer was discovered. Pancreatic metastasis of breast cancer is extremely rare, and a limited number of patients have been reported in the literature. Here, we report an additional case of this rare tumor and the problems correlating with its diagnosis.
Asunto(s)
Neoplasias de la Mama/secundario , Carcinoma Ductal/secundario , Neoplasias Pancreáticas/diagnóstico , Adenocarcinoma/diagnóstico , Adulto , Neoplasias de la Mama/complicaciones , Neoplasias de la Mama/diagnóstico , Neoplasias de la Mama/tratamiento farmacológico , Carcinoma Ductal/complicaciones , Carcinoma Ductal/diagnóstico , Carcinoma Ductal/tratamiento farmacológico , Quimioterapia Adyuvante , Femenino , Humanos , Pancreatectomía , Neoplasias Pancreáticas/cirugía , Neoplasias PancreáticasRESUMEN
BACKGROUND: Pulmonary tumor embolism (PTE) is difficult to detect before death, and it is unclear whether the discrepancy between antemortem clinical and postmortem diagnosis improves with the advance of the diagnostic technologies. In this study we determined the incidence of PTE and analyzed the discrepancy between antemortem clinical and postmortem diagnosis. METHODS: We performed a retrospective autopsy study on patients with the history of malignant solid tumors from 1990 to 2020 and reviewed all the slides of the patients with PTE. We also analyzed the discrepancies between antemortem clinical and postmortem diagnosis in 1999, 2009 and 2019 by using the Goldman criteria. Goldman category major 1 refers to cases in which an autopsy diagnosis was the direct cause of death and was not recognized clinically, but if it had been recognized, it may have changed treatment or prolonged survival. RESULTS: We found 20 (3%) cases with PTE out of the 658 autopsy cases with solid malignancies. Out of these 20 cases, urothelial carcinoma (30%, 6/20) and invasive ductal carcinoma of the breast (4/20, 20%) were the most common primary malignancies. Seven patients with shortness of breath died within 3-17 days (average 8.4±2.2 days) after onset of the symptoms. Pulmonary embolism was clinically suspected in seven out of twenty (35%, 7/20) patients before death, but only two patients (10, 2/20) were diagnosed by imaging studies before death. The rate of Goldman category major 1 was 13.2% (10/76) in 1999, 7.3% (4/55) in 2009 and 6.9% (8/116) in 2019. Although the rate of Goldman category major 1 appeared decreasing, the difference was not statistically significant. The autopsy rate was significantly higher in 2019 (8.4%, 116/1386) than in 2009 (4.4%, 55/1240). CONCLUSIONS: The incidence of PTE is uncommon. Despite the advances of the radiological techniques, radiological imaging studies did not detect the majority of PTEs. The discrepancy between the antemortem clinical and the postmortem diagnosis has not improved significantly over the past 30 years, emphasizing the value of autopsy.
Asunto(s)
Neoplasias/patología , Embolia Pulmonar/diagnóstico , Adulto , Anciano , Anciano de 80 o más Años , Autopsia , Neoplasias de la Mama/complicaciones , Neoplasias de la Mama/diagnóstico , Neoplasias de la Mama/patología , Carcinoma Ductal/complicaciones , Carcinoma Ductal/diagnóstico , Carcinoma Ductal/patología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neoplasias/complicaciones , Neoplasias/diagnóstico , Embolia Pulmonar/complicaciones , Estudios Retrospectivos , Neoplasias de la Vejiga Urinaria/complicaciones , Neoplasias de la Vejiga Urinaria/diagnóstico , Neoplasias de la Vejiga Urinaria/patologíaRESUMEN
Anal duct carcinoma is an uncommon malignancy of the glands of the anal duct. This entity poses a diagnostic challenge, both clinically and histologically. This article describes histopathologic findings in a case of anal duct carcinoma, including the initial diagnosis on biopsy and subsequent cytology specimens. Additionally, differential diagnoses of this neoplasm are discussed. With a high index of suspicion, and attention to histological and immunohistochemical features, anal duct carcinoma can be accurately diagnosed both on biopsy and on cytology.
Asunto(s)
Neoplasias del Ano/patología , Ascitis/patología , Carcinoma Ductal/diagnóstico , Citodiagnóstico/métodos , Dolor Abdominal/diagnóstico , Dolor Abdominal/etiología , Ascitis/etiología , Biopsia/métodos , Carcinoma Ductal/complicaciones , Carcinoma Ductal/metabolismo , Estreñimiento/diagnóstico , Estreñimiento/etiología , Diagnóstico Diferencial , Femenino , Cuidados Paliativos al Final de la Vida , Humanos , Queratinas/metabolismo , Persona de Mediana Edad , Paracentesis/métodos , Neoplasias Peritoneales/diagnósticoRESUMEN
We report a rare case of salivary duct carcinoma and we study its clinical and evolutionary features. A 64-year-old patient was referred for right peripheral facial paralysis. MRI showed suspected formation of the right parotid gland. Treatment included total parotidectomy and ipsilateral neck lymph node dissection. The histology concluded to a ductal carcinoma of the parotid with lymph node metastasis. Radiation therapy has been indicated. Salivary duct carcinoma of the parotid gland is a highly aggressive and uncommon tumor. Treatment of localized forms is based on surgery and radiotherapy.
Asunto(s)
Carcinoma Ductal , Neoplasias de la Parótida , Carcinoma Ductal/complicaciones , Carcinoma Ductal/diagnóstico por imagen , Carcinoma Ductal/patología , Carcinoma Ductal/terapia , Parálisis Facial/etiología , Humanos , Escisión del Ganglio Linfático , Metástasis Linfática , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Neoplasias de la Parótida/complicaciones , Neoplasias de la Parótida/diagnóstico por imagen , Neoplasias de la Parótida/patología , Neoplasias de la Parótida/terapiaAsunto(s)
Neoplasias de los Conductos Biliares/diagnóstico , Carcinoma Ductal/diagnóstico , Neoplasias de la Vesícula Biliar/diagnóstico , Vesícula Biliar/patología , Conductos Pancreáticos/patología , Mala Unión Pancreaticobiliar/diagnóstico , Adenocarcinoma/complicaciones , Adenocarcinoma/diagnóstico , Adenocarcinoma/cirugía , Anciano , Neoplasias de los Conductos Biliares/complicaciones , Neoplasias de los Conductos Biliares/cirugía , Carcinoma Ductal/complicaciones , Carcinoma Ductal/cirugía , Colecistectomía , Femenino , Vesícula Biliar/cirugía , Neoplasias de la Vesícula Biliar/complicaciones , Neoplasias de la Vesícula Biliar/cirugía , Humanos , Conductos Pancreáticos/cirugía , Mala Unión Pancreaticobiliar/complicaciones , Mala Unión Pancreaticobiliar/cirugía , PancreaticoduodenectomíaAsunto(s)
Disnea/etiología , Neoplasias Cardíacas/diagnóstico , Ventrículos Cardíacos/patología , Radioterapia/efectos adversos , Sarcoma/diagnóstico , Anciano , Neoplasias de la Mama/complicaciones , Neoplasias de la Mama/terapia , Carcinoma Ductal/complicaciones , Carcinoma Ductal/terapia , Quimioradioterapia/efectos adversos , Angiografía por Tomografía Computarizada , Diagnóstico Diferencial , Femenino , Neoplasias Cardíacas/complicaciones , Neoplasias Cardíacas/patología , Humanos , Imagen por Resonancia Magnética , Mastectomía , Recurrencia Local de Neoplasia/complicaciones , Recurrencia Local de Neoplasia/terapia , Sarcoma/complicaciones , Sarcoma/patologíaRESUMEN
Gastrointestinal stromal tumor (GIST), despite the fact that it accounts for less than 5% of all sarcomas, is the most common mesenchymal tumor of the alimentary canal. Synchronous and metachronous stromal tumors are very rare findings. Only a few such cases can be found in the literature, and yet most of them is connected with Von Recklinghausen's disease or Carney's triad in which it is proved a much higher frequency of occurrence of this kind of tumors. CASE REPORT: We present a case of 64 years old women, who was diagnosed with invasive ductal carcinoma of both breast due to screening mammography. Patent was qualified to bilateral mastectomy. Perioperative computer tomography scan revealed an additional pathological abnormality situated beyond stomach light, which after resection and immunohistochemistry was found to be a gastrointestinal stromal tumor. This case emphasize the problem of synchronous stromal tumors, the detection of which is often difficult due to nonspecific symptoms. Despite the fact that the most common localization of coexisting tumors is the digestive tract, one should remember about the possibility of occurrence in less frequent locations such as the breast.
Asunto(s)
Neoplasias de la Mama/complicaciones , Carcinoma Ductal/complicaciones , Tumores del Estroma Gastrointestinal/complicaciones , Neoplasias Gástricas/complicaciones , Neoplasias de la Mama/diagnóstico por imagen , Neoplasias de la Mama/cirugía , Carcinoma Ductal/diagnóstico por imagen , Carcinoma Ductal/cirugía , Femenino , Tumores del Estroma Gastrointestinal/diagnóstico por imagen , Tumores del Estroma Gastrointestinal/cirugía , Humanos , Mastectomía , Persona de Mediana Edad , Estómago/diagnóstico por imagen , Estómago/cirugía , Neoplasias Gástricas/diagnóstico por imagen , Neoplasias Gástricas/cirugíaRESUMEN
Ductal carcinoma in situ is a noninvasive precancer condition. The treatment resembles the treatment of invasive breast cancer. The aim of this exploratory study was to gain knowledge on the level of postoperative pain, sensory disturbances, and distress among a small group of Danish women with ductal carcinoma in situ who had sentinel lymph node biopsy in order to plan a population study. A subgroup of patients with ductal carcinoma in situ (n = 20) was compared to patients with invasive breast cancer (n = 455) at time of diagnosis and after 12 months. Six patients were interviewed on the impact of the diagnosis and life after treatment. We found no significant difference in reported sensory disturbances or pain after 12 months between the groups. More than one-third (39%) of ductal carcinoma in situ patients reported moderate to severe distress (≥ 7 on the Distress Thermometer) at time of diagnosis decreasing to 10% after 12 months. Similarly 36% of breast cancer patients reported distress at time of diagnosis and 10% after 12 months. Interviews confirmed that ductal carcinoma in situ patients experienced distress and also uncovered physical problems and rehabilitation needs. The study indicates that women with ductal carcinoma in situ seem to suffer from pain and distress. The study highlights the need for a large study in order to validate the findings. Additional efforts may be needed to improve patients' understanding of diagnosis of ductal carcinoma in situ and alleviate psychological morbidity and physical restraints related to the condition.
Asunto(s)
Carcinoma Ductal/complicaciones , Costo de Enfermedad , Dolor Postoperatorio/epidemiología , Trastornos de la Sensación/epidemiología , Anciano , Neoplasias de la Mama/complicaciones , Neoplasias de la Mama/cirugía , Carcinoma Ductal/epidemiología , Carcinoma Ductal/cirugía , Estudios de Cohortes , Femenino , Grupos Focales , Humanos , Persona de Mediana Edad , Países Bajos/epidemiología , Dimensión del Dolor/métodos , Estudios Prospectivos , Investigación Cualitativa , Apoyo Social , Estrés Psicológico/complicacionesRESUMEN
Most breast cancers originate in the ductal epithelium and are referred to as invasive ductal carcinoma. In this study we report on the clinical procedures adopted to diagnose myiasis in association with infiltrating metastatic breast carcinoma in a female patient. A 41 years old woman came to the Federal Hospital of Andaraí complaining of intense itching, warmth, redness and hardening of the breast, which had acquired the aspect of an orange peel. A lesion in the left breast was cavitated, dimpled, had fetid odor, and had fibrotic and infected air nodules filled with exudate and Dipteran larvae. The tissue was cleaned and 33 larvae were extracted. The patient was hospitalized and received Ivermectin. Eighteen of the larvae extracted from the patient were placed in 70% alcohol, and twelve were placed in a container with sterile wood shavings under controlled conditions until they metamorphosed into adults. The taxonomic identification of the flies revealed that the culprit was Cochliomyia hominivorax. A histopathological exam conducted three months earlier had revealed infiltrating ductal carcinoma. Two months after the myiasis treatment, the breast tissue had healed. The patient had waited ten days from the onset of the myiasis to seek treatment, and that delay interfered negatively in the prognosis of both the neoplasm and the myiasis. This study is relevant to public health in view of the strong social impact of myiasis.
Asunto(s)
Neoplasias de la Mama/complicaciones , Carcinoma Ductal/complicaciones , Miasis/complicaciones , Adulto , Animales , Antiparasitarios/uso terapéutico , Neoplasias de la Mama/parasitología , Carcinoma Ductal/parasitología , Femenino , Humanos , Ivermectina/uso terapéutico , Larva , Miasis/diagnóstico , Miasis/tratamiento farmacológicoRESUMEN
BACKGROUND: A controversy of the role of Epstein-Barr virus (EBV) infection in breast carcinomas has been reported in the literature. OBJECTIVES: We carried on this research to explore possible association between EBV infection and breast invasive ductal carcinoma (IDC) in Egyptian women attending our center. STUDY DESIGN: This study carried out at Sohag university hospital on 84 paraffin embedded samples of breast tissue, of them 42 breast IDC as the case group and 42 breast fibroadenomas as the control group. Nested PCRand immunohistochemistry (IHC) done separately for all samples to identify the Epstein-Barr nuclear antigen-1 (EBNA-1) gene and EBV latent membrane protein-1 (LMP-1) respectively, in breast cancer cells and controls. RESULTS: Specimen considered positive when both (EBNA-1) gene and LMP-1 were detected using PCR and IHC separately for the same sample, this was achieved by 10/42 (23.81%) of breast IDC (case group) and 6/42 (14.29%) of breast fibro-adenomas (control group) (P-value=0.4). Nodal involvement was the only parameter that demonstrated a significant statistical relationship with EBV presence in cancerous tissue with p-value=0.003. CONCLUSION: Our research could not find a significant statistical association between EBV infection and breast IDC in Egyptian women attending our center, but, there might be an association between the existence of EBV and tumor aggressiveness.
Asunto(s)
Neoplasias de la Mama/epidemiología , Carcinoma Ductal/epidemiología , Infecciones por Virus de Epstein-Barr/epidemiología , Herpesvirus Humano 4/patogenicidad , Adulto , Anciano , Neoplasias de la Mama/genética , Neoplasias de la Mama/virología , Carcinoma Ductal/complicaciones , Carcinoma Ductal/genética , Carcinoma Ductal/virología , Egipto/epidemiología , Infecciones por Virus de Epstein-Barr/complicaciones , Infecciones por Virus de Epstein-Barr/genética , Infecciones por Virus de Epstein-Barr/virología , Femenino , Humanos , Persona de Mediana EdadAsunto(s)
Analgésicos Opioides/administración & dosificación , Analgésicos Opioides/toxicidad , Hepatopatías/etiología , Naloxona/uso terapéutico , Oxicodona/administración & dosificación , Oxicodona/toxicidad , Anciano , Dolor en Cáncer/tratamiento farmacológico , Dolor en Cáncer/fisiopatología , Carcinoma Ductal/complicaciones , Carcinoma Ductal/terapia , Preparaciones de Acción Retardada/toxicidad , Combinación de Medicamentos , Sustitución de Medicamentos/efectos adversos , Femenino , Humanos , Oxicodona/uso terapéuticoRESUMEN
This study reports the treatment and local control of advanced breast cancer with a giant ulcer. A 53-year-old woman presented with a large left breast tumor and an associated giant ulcer, with massive exudates, bleeding, and an offensive odor. Histopathological examination revealed an invasive ductal carcinoma(Luminal B type). Computed tomography(CT) showed multiple metastases to the lymph nodes, lungs, liver and bones. The patient received chemotherapy with a combina- tion of paclitaxel(PTX 90mg/m / 2)and bevacizumab(BEV 10 mg/kg). After 4 courses of chemotherapy, there was a significant reduction in the tumor size, the discharge of exudates and bleeding as well as lumbago and femoral pain. High CEA and CA15-3 levels had been normalized and CT showed a remarkable decrease in metastases. Compared to the tumor itself, the ulcer associated with it had shown a smaller decrease in size, and there was the possibility of perforation in the thin chest wall. Suspecting these outcomes to the adverse events of BEV, its use was discontinued, and starting with course 5 of chemothera- py, we administrated only PTX(90mg/m2). Subsequently, the ulcer showed obvious granulation and was infected. CT of the chest prior to the second course of PTX revealed pleurisy, pneumonia and atelectasis. Following the administration of antibiotics, while infection in the ulcer had subsided, pleurisy and pneumonia continued, with increased right pleural effusion, which finally required drainage. We had to discontinue the administration of PTX. BEV, although effective as first-line therapy, has the adverse effect of slowing wound healing. Therefore, even though the combination therapy of BEV and PTX is markedly effective for systemic therapy, it should be altered for local wound healing as in this case.
Asunto(s)
Neoplasias de la Mama/terapia , Carcinoma Ductal/terapia , Úlcera/etiología , Biopsia , Neoplasias de la Mama/complicaciones , Neoplasias de la Mama/patología , Carcinoma Ductal/complicaciones , Quimioradioterapia , Femenino , Humanos , Persona de Mediana Edad , Invasividad NeoplásicaRESUMEN
ABSTRACT Most breast cancers originate in the ductal epithelium and are referred to as invasive ductal carcinoma. In this study we report on the clinical procedures adopted to diagnose myiasis in association with infiltrating metastatic breast carcinoma in a female patient. A 41 years old woman came to the Federal Hospital of Andaraí complaining of intense itching, warmth, redness and hardening of the breast, which had acquired the aspect of an orange peel. A lesion in the left breast was cavitated, dimpled, had fetid odor, and had fibrotic and infected air nodules filled with exudate and Dipteran larvae. The tissue was cleaned and 33 larvae were extracted. The patient was hospitalized and received Ivermectin. Eighteen of the larvae extracted from the patient were placed in 70% alcohol, and twelve were placed in a container with sterile wood shavings under controlled conditions until they metamorphosed into adults. The taxonomic identification of the flies revealed that the culprit was Cochliomyia hominivorax. A histopathological exam conducted three months earlier had revealed infiltrating ductal carcinoma. Two months after the myiasis treatment, the breast tissue had healed. The patient had waited ten days from the onset of the myiasis to seek treatment, and that delay interfered negatively in the prognosis of both the neoplasm and the myiasis. This study is relevant to public health in view of the strong social impact of myiasis.
Asunto(s)
Humanos , Animales , Femenino , Adulto , Neoplasias de la Mama/complicaciones , Carcinoma Ductal/complicaciones , Miasis/complicaciones , Antiparasitarios/uso terapéutico , Neoplasias de la Mama/parasitología , Carcinoma Ductal/parasitología , Ivermectina/uso terapéutico , Larva , Miasis/diagnóstico , Miasis/tratamiento farmacológicoAsunto(s)
Angiomatosis/diagnóstico , Enfermedades de la Mama/diagnóstico , Neoplasias de la Mama/diagnóstico , Carcinoma Ductal/diagnóstico , Hiperplasia/diagnóstico , Neurofibromatosis 1/diagnóstico , Adulto , Angiomatosis/complicaciones , Angiomatosis/patología , Antígenos CD34/análisis , Biomarcadores de Tumor/análisis , Biopsia , Enfermedades de la Mama/complicaciones , Enfermedades de la Mama/patología , Neoplasias de la Mama/patología , Carcinoma Ductal/complicaciones , Carcinoma Ductal/patología , Histocitoquímica , Humanos , Hiperplasia/complicaciones , Hiperplasia/patología , Inmunohistoquímica , Masculino , Microscopía , Neurofibromatosis 1/complicaciones , Neurofibromatosis 1/patología , Proteínas S100/análisisAsunto(s)
Trastorno Bipolar/complicaciones , Neoplasias de la Mama/diagnóstico , Carcinoma Ductal/diagnóstico , Pulmón/patología , Navegación de Pacientes , Trastorno por Déficit de Atención con Hiperactividad/complicaciones , Trastorno Bipolar/terapia , Neoplasias de la Mama/complicaciones , Carcinoma Ductal/complicaciones , Carcinoma de Pulmón de Células no Pequeñas/complicaciones , Trastorno Depresivo/complicaciones , Diagnóstico Diferencial , Manejo de la Enfermedad , Femenino , Hospitalización , Humanos , Neoplasias Pulmonares/complicaciones , Persona de Mediana Edad , Cooperación del PacienteRESUMEN
Cancer immunotherapies are increasingly effective in the clinic, especially immune checkpoint blockade delivered to patients who have T cell-infiltrated tumors. Agonistic CD40 mAb promotes stromal degradation and, in combination with chemotherapy, drives T cell infiltration and de novo responses against tumors, rendering resistant tumors susceptible to current immunotherapies. Partnering anti-CD40 with different treatments is an attractive approach for the next phase of cancer immunotherapies, with a number of clinical trials using anti-CD40 combinations ongoing, but the optimal therapeutic regimens with anti-CD40 are not well understood. Pancreatic ductal adenocarcinoma (PDA) is classically resistant to immunotherapy and lacks baseline T cell infiltration. In this study, we used a tumor cell line derived from a genetically engineered mouse model of PDA to investigate alterations in the sequence of anti-CD40 and chemotherapy as an approach to enhance pharmacological delivery of chemotherapy. Unexpectedly, despite our previous studies showing anti-CD40 treatment after chemotherapy is safe in both mice and patients with PDA, we report in this article that anti-CD40 administration <3 d in advance of chemotherapy is lethal in more than half of treated C57BL/6 mice. Anti-CD40 treatment 2 or 3 d before chemotherapy resulted in significantly increased populations of both activated myeloid cells and macrophages and lethal hepatotoxicity. Liver damage was fully abrogated when macrophage activation was blocked using anti-CSF-1R mAb. These studies highlight the dual nature of CD40 in activating both macrophages and T cell responses, and the need for preclinical investigation of optimal anti-CD40 treatment regimens for safe design of clinical trials.